CompletedNot Applicable

Integrating Halotherapy Into Preseason Training Improves Respiratory and Aerobic Performance in Elite Female Soccer Players

Turkey (Türkiye)28 participantsStarted 2022-04-05

Plain-language summary

This randomized controlled trial aimed to investigate the effects of a 12-week halotherapy intervention on respiratory muscle strength, pulmonary function, aerobic capacity, and intermittent running performance in elite female soccer players. Participants were randomly assigned to either a halotherapy group or a control group. Both groups followed the same preseason soccer training program, while the halotherapy group additionally received regular halotherapy sessions. Pre- and post-intervention assessments included spirometric measurements, respiratory muscle strength, estimated VO₂max, and Yo-Yo Intermittent Recovery Test Level 1 performance.

Who can participate

Age range18 Years – 30 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female soccer players aged 18-30 years * Competing in the Turkish Women's First League * Minimum of 5 years of competitive soccer experience * Regular training ≥10 hours per week * Free from injury at study entry * Non-smokers * Not using chronic medication * Provided written informed consent Exclusion Criteria: * Presence of respiratory, cardiovascular, or metabolic disease * Current musculoskeletal injury * Smoking * Pregnancy * Use of medications affecting respiratory or cardiovascular function

What they're measuring

Maximal Expiratory Pressure (MEP)

Timeframe: 12 week

Maximal Inspiratory Pressure (MIP)

Timeframe: 12 week

Aerobic Capacity (VO₂max estimate)

Timeframe: 12 week

Trial details

NCT IDNCT07406386

SponsorGümüşhane Universıty

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-07-15

View on ClinicalTrials.gov More Aerobic Performance trials